Merkliste 
 1 Ergebnisse 
 
1

Second-line FOLFOX chemotherapy versus active symptom contr..:

Lamarca, Angela ; Palmer, Daniel H ; Wasan, Harpreet Singh...
Lamarca , A , Palmer , D H , Wasan , H S , Ross , P J , Ma , Y T , Arora , A , Falk , S , Gillmore , R , Wadsley , J , Patel , K , Anthoney , A , Maraveyas , A , Iveson , T , Waters , J S , Hobbs , C , Barber , S , Ryder , W D , Ramage , J , Davies , L M , Bridgewater , J A & Valle , J W 2021 , ' Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial ' , The Lancet Oncology , vol. 22 , no. 5 , pp. 690-701 . https://doi.org/10.1016/S1470-2045(21)00027-9.  , 2021